Literature DB >> 22907809

Preventability analysis of adverse drug reactions detected in two internal medicine departments in Romania.

Andreea Farcas1, Camelia Bucsa, Aura Sinpetrean, Daniel Leucuta, Cristina Mogosan, Dan Dumitrascu, Andrei Cadariu Achimas, Marius Bojita.   

Abstract

In order to improve patient safety, systematic analysis of common and repetitive patterns of preventable adverse drug reactions (pADRs) in the clinical setting should be performed regularly in order to propose adequate prevention strategies. Our aim is to evaluate the preventability of all ADRs collected in a drug information research center database, by spontaneous reporting and clinical surveillance in two internal medicine departments. One reviewer systematically reevaluated all the cases stored in the database. ADRs were deemed preventable if they were due to: a contraindication, an inadequate dose, a drug interaction, an inappropriate prescribing decision for the patient's condition, inadequate monitoring, self-medication, or non-adherence to therapy. Out of 251 ADRs evaluated, 103 (41 %) were considered preventable. Out of the total pADRs, 86.4 % were serious. The most frequent adverse outcomes affected the gastrointestinal system (21.4 %), followed by the renal (11.6 %), metabolic (10.7 %), vascular (10.7 %) and hepatic (6.8 %) systems. Acenocoumarol (28 %), diclofenac (12.6 %), digoxin and furosemide accounted for more than 50 % of all preventable reports. One of up to three factors was involved in the preventability of the analyzed reports. Drug-drug interactions were the cause of 49.5 % of the pADRs. Inappropriate dose accounted for 17.5 % reports out of the total pADRs, inappropriate monitoring for 9.7 % reports, history of allergy to drug or drug class for 5.8 % reports and administration of a contraindicated drug for 4.8 % reports. Identifying prevalent pADRs in this study indicates a clear target for prevention strategies: drug prescription, with a special emphasis on drug interactions.

Entities:  

Mesh:

Year:  2012        PMID: 22907809     DOI: 10.1007/s11739-012-0843-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  32 in total

1.  Focusing on the preventability of adverse drug reactions.

Authors:  G T Schumock; J P Thornton
Journal:  Hosp Pharm       Date:  1992-06

2.  Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study.

Authors:  A P Jonville-Béra; F Béra; E Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

3.  Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.

Authors:  Cornelis S van der Hooft; Miriam C J M Sturkenboom; Kees van Grootheest; Herre J Kingma; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.

Authors:  Alexandra Alexopoulou; Spyros P Dourakis; Demosthenes Mantzoukis; Thomas Pitsariotis; Anna Kandyli; Melanie Deutsch; Athanasios J Archimandritis
Journal:  Eur J Intern Med       Date:  2008-03-11       Impact factor: 4.487

5.  Preventable drug related mortality in a Swedish population.

Authors:  Anna K Jönsson; Katja M Hakkarainen; Olav Spigset; Henrik Druid; Anne Hiselius; Staffan Hägg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-02       Impact factor: 2.890

6.  Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania.

Authors:  Andreea Farcas; Aura Sinpetrean; Cristina Mogosan; Mariana Palage; Oliviu Vostinaru; Marius Bojita; Dan Dumitrascu
Journal:  Eur J Intern Med       Date:  2010-06-23       Impact factor: 4.487

7.  Frequency and cost of serious adverse drug reactions in a department of general medicine.

Authors:  N Moore; D Lecointre; C Noblet; M Mabille
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

Review 8.  Nature of preventable adverse drug events in hospitals: a literature review.

Authors:  Penkarn Kanjanarat; Almut G Winterstein; Thomas E Johns; Randy C Hatton; Ricardo Gonzalez-Rothi; Richard Segal
Journal:  Am J Health Syst Pharm       Date:  2003-09-01       Impact factor: 2.637

9.  Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.

Authors:  Balthasar L Hug; Daniel J Witkowski; Colin M Sox; Carol A Keohane; Diane L Seger; Catherine Yoon; Michael E Matheny; David W Bates
Journal:  J Gen Intern Med       Date:  2009-11-06       Impact factor: 5.128

10.  Using prospective clinical surveillance to identify adverse events in hospital.

Authors:  Alan J Forster; Jim R Worthington; Steven Hawken; Michael Bourke; Fraser Rubens; Kaveh Shojania; Carl van Walraven
Journal:  BMJ Qual Saf       Date:  2011-03-01       Impact factor: 7.035

View more
  2 in total

1.  Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020.

Authors:  Huaqiao Jiang; Yanhua Lin; Weifang Ren; Zhonghong Fang; Yujuan Liu; Xiaofang Tan; Xiaoqun Lv; Ning Zhang
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

2.  Preventable medication harm across health care settings: a systematic review and meta-analysis.

Authors:  Alexander Hodkinson; Natasha Tyler; Darren M Ashcroft; Richard N Keers; Kanza Khan; Denham Phipps; Aseel Abuzour; Peter Bower; Anthony Avery; Stephen Campbell; Maria Panagioti
Journal:  BMC Med       Date:  2020-11-06       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.